Rabbit Polyclonal ALEX antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human GNAS aa 300-450.
View Alternative Names
GNAS1, GNAS, Protein ALEX, Alternative gene product encoded by XL-exon
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GNAS antibody (AB235959)
Paraffin-embedded human brain tissue stained for G protein alpha S using ab235959 at 1/600 dilution in immunohistochemical analysis.
After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30 minutes at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized tissue using an HRP conjugated SP system.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GNAS antibody (AB235959)
Paraffin-embedded human small intestine tissue stained for G protein alpha S using ab235959 at 1/600 dilution in immunohistochemical analysis.
After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30 minutes at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized tissue using an HRP conjugated SP system.
- WB
Supplier Data
Western blot - Anti-GNAS antibody (AB235959)
All lanes:
Western blot - Anti-GNAS antibody (ab235959) at 1/500 dilution
All lanes:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate
Secondary
All lanes:
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 46 kDa
false
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-GNAS antibody (AB235959)
4% paraformaldehyde-fixed, 0.2% Triton X-100-permeabilized MCF7 (Human breast adenocarcinoma cell line) cells stained for G protein alpha S (Green) using ab235959 at 1/200 dilution in ICC/IF. Counterstained with DAPI (blue). The secondary antibody was Alexa Fluor® 488-conjugated Goat Anti-Rabbit IgG (H+L).
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
GNAS protein mediates the action of hormones and neurotransmitters by activating the cyclic AMP (cAMP) signaling pathway. It forms part of the G protein complex specifically the G protein-coupled receptors (GPCRs) where it acts as the alpha subunit interacting with beta and gamma subunits. This interaction facilitates the conversion of GDP to GTP leading to downstream activation of adenylate cyclase which increases intracellular cAMP levels and triggers various cellular responses.
Pathways
GNAS protein is pivotal in the cAMP signaling pathway and the MAPK/ERK pathway. Within these pathways it works closely with adenylate cyclase enzymes which further influence numerous physiological processes such as metabolism and cell growth. The protein's activity also interlinks with other G proteins contributing to a wide range of cellular reactions and feedback mechanisms.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
PLoS pathogens 20:e1012483 PubMed39226326
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature 611:173-179 PubMed36289326
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com